Arshad Quadri : 新型经导管三尖瓣置换系统的安全性、有效性和生物相容性
论坛:2022 第二届国际心血管3D打印技术高峰论坛
相关专家
  • West Hartford, CT, USA
    Arshad Quadri 博士长期投身于医疗创新,他拥有50项已授权和已发表的专利,并且发表了大量高水平文章。创立了 CardiAQ经导管二尖瓣置换技术,并担任TMVR业务的医疗事务副总裁,支持带教美国早期可行性研究的临床手术。后期他创立inQB8,提供心血管创新医疗器械解决方案。 Dr. Arshad Quadri has experienced many years of medical innovation. He holds 50 licensed and published patents and has published a large number of high-level articles. While practicing at St. Francis Hospital in Hartford, Conn., he was one of the leading surgeons in endovascular aortic transplantation for the treatment of aortic aneurysms and maintains a strong interest in the treatment of ischemic/structural heart disease. He founded transcatheter mitral valve replacement technology using CardiAQ and served as Vice President of Medical Affairs for the TMVR business, supporting clinical procedures that taught early feasibility studies in the United States. Later, he founded inQB8, which provides innovative cardiovascular medical device solutions.